Author: Ken Dropiewski

Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019

MIAMI–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced technology – the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology – at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting in Miami. Penumbra JET […]

ZOLL Acquires Mobilize RRS LLC.

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired substantially all of the assets of Mobilize RRS LLC., of Pittsford, N.Y., a privately held company that markets the Mobilize Rescue Systems app and associated rescue kits, which are designed […]

EBR Systems Awarded Prestigious Forfait Innovation Package for WiSE CRT System by French Ministry of Social Affairs and Health

SUNNYVALE, Calif., July 22, 2019 /PRNewswire/ — EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the College of the French National Authority for Health (Haute Autorite de Sante, HAS) awarded a Forfait Innovation Package for the company’s WiSE™ Cardiac Resynchronization Therapy (CRT) System. […]

Total Brain Joins the American Heart Association’s Center for Health Technology & Innovation to Study Uses of Heart Rate Variability Data to Reduce Stress and Risk of Cardiovascular Incidents

SAN FRANCISCO, June 22, 2019 /PRNewswire/ — Total Brain, a neuroscience-based mental health and fitness platform, is joining the American Heart Association’s Center for Health Technology & Innovation’s (the Center) Innovators Network. The Association’s Center is focused on building and fostering health technologies and relationships in pursuit of innovative and scalable solutions across the healthcare […]

MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi

SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced updates related to its hypertrophic cardiomyopathy (HCM) treatment portfolio, including lead therapeutic candidate, mavacamten. Patient screening has closed for the Phase 3 EXPLORER-HCM registrational clinical study to assess the effect of mavacamten in treating […]

Olivier Chaudoir Joins BioSig as Director of Marketing

Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today announced that Mr. Olivier Chaudoir joined the Company as Director of Marketing. Mr. Chaudoir brings to […]

New study finds both components of blood pressure predict heart attack, stroke risk

OAKLAND, Calif., July 17, 2019 /PRNewswire/ — Both numbers in a blood pressure reading — the “upper” systolic and the “lower” diastolic — independently predicted the risk of heart attack or stroke in a very large Kaiser Permanente study that included more than 36 million blood pressure readings from more than 1 […]

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency

VANCOUVER, July 17, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has received written notification (the “Nasdaq […]